Conflict of interest: None declared.
The Secondary Prevention of Small Subcortical Strokes (SPS3) study
Article first published online: 26 JAN 2011
© 2011 The Authors. International Journal of Stroke © 2011 World Stroke Organization
International Journal of Stroke
Volume 6, Issue 2, pages 164–175, April 2011
How to Cite
Benavente, O. R., White, C. L., Pearce, L., Pergola, P., Roldan, A., Benavente, M.-F., Coffey, C., McClure, L. A., Szychowski, J. M., Conwit, R., Heberling, P. A., Howard, G., Bazan, C., Vidal-Pergola, G., Talbert, R., Hart, R. G. and for the SPS3 Investigators (2011), The Secondary Prevention of Small Subcortical Strokes (SPS3) study. International Journal of Stroke, 6: 164–175. doi: 10.1111/j.1747-4949.2010.00573.x
Funding: SPS3 is an investigator initiated study funded by a cooperative agreement from the National Institute of Neurological Disorders and Stroke of United States (Grant #2 U01 NS38529-04A1). Together with members of the SPS3 Executive and Steering Committees, NINDS project officers directly participate in the execution of the study and oversee the progress. The clopidogrel and matching placebo have been donated by Sanofi-Aventis and Bristol-Myers Squibb. Neither company has any involvement with the design, execution, or analysis of the trial.
- Issue published online: 4 MAR 2011
- Article first published online: 26 JAN 2011
- 15Prognosis of lacunar stroke patients in association with leukoaraiosis. Stroke 2000; 32:366., , ,
- 16White matter abnormalities in lacunar stroke patients. Stroke 2000; 32:343., , , , ,
- 18Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010; 9:689–701.
- 20Secondary Prevention of Small Subcortical Strokes (SPS3) pilot trial: final results. Stroke 2003; 34:238–322., , et al.
- 21Is there a different effect of clopidogrel plus aspirin versus clopidogrel alone on stroke patients with small vessel disease and large artery atherosclerosis? Analysis from MATCH. Stroke 2007; 38:522., , , ,
- 36Chinese Acute Stroke Trial Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 1997; 349:1641–9.
- 38Cilostazol Stroke Prevention Study: a placebo-controlled double-blind trial for secondary prevention of cerebral infarction. J Stroke Cerebrovasc Dis 2000; 9:147–57., , et al.
- 54Allhat Officers and Coordinators for the Allhat Collaborative Research Group Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288:2981–97.
- 55Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention. Circulation 2006; 113:e409–49., , et al.
- 57Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke 2009; 40:2276–93., , et al.
- 77PfeifferE. (ed): Multidimensional Functional Assessment: The Oars Methodolgy: A Manual. Durham: Center for the Study of Aging and Human Development, 1975.
- 83The effect of an unplanned sample size re-estimation on the type I error rate. Clinical Trials 2010; 7:421., , , ,
- 84Group Sequential Methods with Applications to Clinical Trials. Boca Raton: Chapman & Hall/CRC, 2000.,
- 86Is there a relationship between renal dysfunction and white matter disease? Stroke 2010; 41:142., , , , ,